Results 221 to 230 of about 156,110 (291)

Development of a Brief Mindfulness-Informed Cognitive-Behavioural Therapy Intervention to Pair With Pharmacist-Led Benzodiazepine Tapering for Older Adults: The CSTARS Intervention. [PDF]

Basic Clin Pharmacol Toxicol
Kraemer KM, Wang B, McCann M, Lindenberg J, Anderson TS, Yeh GY.   +5 more
europepmc   +1 more source

A Scoping Systematic Review of Cannabis Use in Endometriosis

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Endometriosis, affecting 6%–10% of reproductive‐age women, causes chronic pelvic pain, dysmenorrhea, and infertility. Current treatments have limitations and consequently there is rising interest in effects of cannabis on pain and inflammation associated with endometriosis.
Kindha McLaren, Simon Erridge, Mikael H. Sodergren   +2 more
wiley   +1 more source

The role of the non‐profit sector in the efficiency of elderly social services: A bootstrap data envelopment analysis study

Annals of Public and Cooperative Economics, EarlyView.
Abstract Social services for the elderly are becoming increasingly important in societies where the elderly population is growing and requires specific attention to ensure their well‐being. Within these services, nursing homes play a key role, and it is therefore vital to ensure efficient management with an assessment according to their characteristics,
Georgina Solaz‐Moreno, Amadeo Fuenmayor Fernández, Teresa Savall Morera   +2 more
wiley   +1 more source

10-year trends in benzodiazepine, opioid, and concurrent use in hip and knee arthroplasty: a nationwide cohort study from the Netherlands. [PDF]

Acta Orthop
Yepes-Calderón M, Nelissen RGHH, Bouvy ML, Rosendaal FR, Van Steenbergen LN, Dahan A, Gademan MGJ.   +6 more
europepmc   +1 more source

Alzheimer's disease and mixed pathologies as a hidden contributor to fatal hypothermia: A large‐scale forensic autopsy‐based study

Brain Pathology, EarlyView.
We investigated neuropathological manifestations of hypothermia in 168 cases. Patients aged 65 years or more constituted 80% of the total cohort. Alzheimer's disease was the most common comorbidity, affecting 40% of all patients. Abstract There is a paucity of autopsy‐based studies providing detailed neuropathological characteristics of fatal ...
Shojiro Ichimata, Koji Yoshida, Ryo Tanaka   +2 more
wiley   +1 more source

Patterns of Drug and Polydrug Detection in Drivers Suspected of Driving Under the Influence of an Intoxicant in Ireland 2019-2020: A Latent Class Analysis. [PDF]

Drug Alcohol Rev
Durand L, O'Kane A, Maguire R, Cusack D, Keenan E, Cousins G.   +5 more
europepmc   +1 more source

Studies retrieved in the literature search which showed that the discontinuation of benzodiazepines conferred benefits on patients. Many of these studies aggregated overall improvements. Studies appear in alphabetic order by surname of first author.

Kyla N. Shade (22138877), Alexis D. Ritvo (16469842), Bernard Silvernail (16469845), A. J. Reid Finlayson (14575811), Jolene E. Bressi (22138880), D. E. Foster (14575814), Ian J. Martin (5645093), Christi Piper (14167659), Peter R. Martin (12457255)   +8 more
openalex   +1 more source

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

British Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, Emma S. J. Robinson   +5 more
wiley   +1 more source

Effects of perioperative benzodiazepine administration on postoperative patient-reported outcomes: a systematic review and meta-analysis of randomised controlled trials. [PDF]

Br J Anaesth
Ge FZ, Zhao K, Au E, Sadeghirad B, Fournier R, Belley-Côté E, Young J, Wang E, Beaver C, Kloppenburg S, Mazer D, Jacobsohn E, Verret M, Spence J.   +13 more
europepmc   +1 more source

Evidence that 5‐HT2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non‐psychedelic drugs

British Journal of Pharmacology, EarlyView.
Background and Purpose Serotonergic psychedelic drugs are under investigation as therapies for various psychiatric disorders, including major depression. Although serotonergic psychedelic drugs are 5‐HT2A receptor agonists, some such agonists are not psychedelic, potentially due to differences in 5‐HT2A receptor ligand bias or signalling efficacy. Here,
Aurelija Ippolito, Sridhar Vasudevan, Shaun Hurley, Gary Gilmour, Frederick Westhorpe, Grant Churchill, Trevor Sharp   +6 more
wiley   +1 more source